TY - JOUR
T1 - Genomic analysis of “microphenotypes” in epilepsy
AU - Stanley, Kate
AU - Hostyk, Joseph
AU - Tran, Linh
AU - Amengual-Gual, Marta
AU - Dugan, Patricia
AU - Clark, Justice
AU - Choi, Hyunmi
AU - Tchapyjnikov, Dmitry
AU - Perucca, Piero
AU - Fernandes, Cecilia
AU - Andrade, Danielle
AU - Devinsky, Orrin
AU - Cavalleri, Gianpiero
AU - Depondt, Chantal
AU - Sen, Arjune
AU - O'Brien, Terence
AU - Heinzen, Erin
AU - Loddenkemper, Tobias
AU - Goldstein, David
AU - Mikati, Mohamed A.
AU - Delanty, Norman
AU - Adcock, Jane
AU - Brazil, Carl
AU - Costello, Daniel
AU - Lewis-Smith, David
AU - Radtke, Rodney
AU - Rees, Mark
AU - Thomas, Ryhs
AU - Arya, Ravindra
AU - Agullar, Cristina Barcia
AU - Gainza-Lein, Marina
AU - Glauser, Tracy A.
AU - Goldstein, David
AU - Joshua, L.
AU - Ann, Goldstein
AU - Lurie, Robert H.
AU - Jackson, null
AU - McDonough, Tiffany L.
AU - Peariso, Katrina
AU - Fernandez, Ivan Sanchez
AU - Sands, Tristan
AU - Sheehan, Theodore
AU - Tasker, Robert C.
AU - Vasquez, Alejandra
AU - Wainright, Mark S.
AU - Wilfong, Angus
AU - Williams, Korwyn
AU - the pSERG Consortium, the EPIGEN Consortium
N1 - Funding Information:
Fundación Alfonso Martín Escudero, Grant/Award Number: 2018‐2019; Epilepsy Research Fund; Pediatric Epilepsy Research Foundation; Epilepsy Foundation of America, Grant/Award Number: EF‐213583 Funding information
Funding Information:
pSERG was funded by the Epilepsy Foundation of America (EF‐213583, Targeted Initiative for Health Outcomes), by the American Epilepsy Society/Epilepsy Foundation of America Infrastructure Award, by the Pediatric Epilepsy Research Foundation, and the Epilepsy Research Fund. Marta Amengual‐Gual was supported by Fundación Alfonso Martín Escudero (2018‐2019). Open access funding provided by IReL.
Publisher Copyright:
© 2021 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2022/1
Y1 - 2022/1
N2 - Large international consortia examining the genomic architecture of the epilepsies focus on large diagnostic subgroupings such as “all focal epilepsy” and “all genetic generalized epilepsy”. In addition, phenotypic data are generally entered into these large discovery databases in a unidirectional manner at one point in time only. However, there are many smaller phenotypic subgroupings in epilepsy, many of which may have unique genomic risk factors. Such a subgrouping or “microphenotype” may be defined as an uncommon or rare phenotype that is well recognized by epileptologists and the epilepsy community, and which may or may not be formally recognized within the International League Against Epilepsy classification system. Here we examine the genetic structure of a number of such microphenotypes and report in particular on two interesting clinical phenotypes, Jeavons syndrome and pediatric status epilepticus. Although no single gene reached exome-wide statistical significance to be associated with any of the diagnostic categories, we observe enrichment of rare damaging variants in established epilepsy genes among Landau–Kleffner patients (GRIN2A) and pediatric status epilepticus patients (MECP2, SCN1A, SCN2A, SCN8A).
AB - Large international consortia examining the genomic architecture of the epilepsies focus on large diagnostic subgroupings such as “all focal epilepsy” and “all genetic generalized epilepsy”. In addition, phenotypic data are generally entered into these large discovery databases in a unidirectional manner at one point in time only. However, there are many smaller phenotypic subgroupings in epilepsy, many of which may have unique genomic risk factors. Such a subgrouping or “microphenotype” may be defined as an uncommon or rare phenotype that is well recognized by epileptologists and the epilepsy community, and which may or may not be formally recognized within the International League Against Epilepsy classification system. Here we examine the genetic structure of a number of such microphenotypes and report in particular on two interesting clinical phenotypes, Jeavons syndrome and pediatric status epilepticus. Although no single gene reached exome-wide statistical significance to be associated with any of the diagnostic categories, we observe enrichment of rare damaging variants in established epilepsy genes among Landau–Kleffner patients (GRIN2A) and pediatric status epilepticus patients (MECP2, SCN1A, SCN2A, SCN8A).
KW - genomics
KW - Jeavons syndrome
KW - microphenotype
KW - pediatric status epilepticus
UR - https://www.scopus.com/pages/publications/85116783520
U2 - 10.1002/ajmg.a.62505
DO - 10.1002/ajmg.a.62505
M3 - Article
C2 - 34569149
AN - SCOPUS:85116783520
SN - 1552-4825
VL - 188
SP - 138
EP - 146
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 1
ER -